In patients with hematologic malignancies and transplant recipients, the combination of voriconazole and anidulafungin has shown a reduction in mortality rates compared to voriconazole monotherapy, although this finding was at the margin of statistical significance [ 13 , 60 , 64 ]. 6.1.6.
← all excerpts
Fungal Infections in Pediatric Patients With Hematologic Malignancies and Stem Cell Transplantation: Impact on the Upper and Lower Respiratory Systems.
1
—
—